Lilly’s Bamlanivimab and Etesevimab
On March 10, Eli Lilly and Company announced new data from the randomized, double-blind, placebo-controlled BLAZE-1 Phase 3 study, demonstrating bamlanivimab (LY-CoV555) 700 mg and…
March 11, 2021
Pharmacy Near Me is not affiliated with or sponsored by any of pharmacies, pharmaceutical companies or other entities mentioned in its news articles, price comparisons, or press releases. All trademarks, copyright images, brands and logos are the property of their owners and right holders. They are used only for representing the products of the right holders. The information found at Pharmacy Near Me is for informational purposes only. It cannot be used as the substitute for professional medical advice. The information on this website is not meant to be used for self-treatment of self-diagnosis. Pharmacy Near Me is not endorsing or recommending any particular pharmaceutical product, pharmacy, pharmaceutical company, or any information on the site. Pharmacy Near Me provides no warranty for prescription drugs or other pharmaceuticals pricing data or other information related to these products. Please ask your doctor for a medical advice before starting, terminating or changing any medical treatment.